Comparison of the Survival Outcomes of Pancreatic Cancer and Intraductal Papillary Mucinous Neoplasms-Reference-Cited by-同舟云学术

Comparison of the Survival Outcomes of Pancreatic Cancer and Intraductal Papillary Mucinous Neoplasms

Published:2018-09 Issue:8 Volume:47 Page:974-979
ISSN:1536-4828
Container-title:Pancreas
language:en
Short-container-title:Pancreas

Author:

Yamada Suguru,Fujii Tsutomu,Hirakawa Akihiro,Takami Hideki,Suenaga Masaya,Hayashi Masamichi,Niwa Yukiko,Hattori Norifumi,Iwata Naoki,Kanda Mitsuro,Tanaka Chie,Kobayashi Daisuke,Nakayama Goro,Koike Masahiko,Fujiwara Michitaka,Kodera Yasuhiro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference31 articles.

1. Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society;Pancreas,2012

2. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial;JAMA,2013

3. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01);Lancet,2016

4. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience;Ann Surg,2004

5. Pancreatic intraductal papillary-mucinous neoplasms: a new and evolving entity;Virchows Arch,2007

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study;British Journal of Surgery;2024-04

2. Prognostic Strength of CA 19-9, Demographic Parameters, and Maximum Standardized Uptake Value of Baseline 18F-FDG PET/CT in Treatment-naïve Patients with Pancreatic Carcinoma;Indian Journal of Nuclear Medicine;2024-03

3. Early Cancerous Lesions of the Pancreas and Ampulla;Gastroenterology Clinics of North America;2024-03

4. A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas?;Therapeutic Advances in Medical Oncology;2024-01

5. Systematic review of challenging issues in pathology of intraductal papillary mucinous neoplasms;Pancreatology;2023-11